Donor selection and management

Seminars in Respiratory and Critical Care Medicine

Volumn 34, Issue 3, 2013, Pages 361-370

  Snell, Gregory I ^a   Paraskeva, Miranda ^a   Westall, Glen P ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

donation after cardiac death; donor management; ex vivo lung perfusion; lung transplantation; organ donor

Indexed keywords

ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; CADAVER; DONOR SELECTION; HEART DEATH; HUMAN; LUNG INFECTION; LUNG PERFUSION; LUNG TRANSPLANTATION; MEDICAL HISTORY; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; RESUSCITATION; SMOKING;

ANIMALS; DEATH; DONOR SELECTION; HUMANS; LUNG DISEASES; LUNG TRANSPLANTATION; TIME FACTORS; TISSUE AND ORGAN HARVESTING; TISSUE DONORS; TREATMENT OUTCOME;

EID: 84879943317     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0033-1348464     Document Type: Article

References (104)

1. Christie J. D., Edwards L. B., Kucheryavaya A. Y., et al. International Society of Heart and Lung Transplantation The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012. J Heart Lung Transplant: 2012; 31 10 1073 1086
2. Levvey B. J., Harkess M., Hopkins P., et al. Excellent clinical outcomes from a national donation-after-determination-of-cardiac-death lung transplant collaborative. Am J Transplant: 2012; 12 9 2406 2413
3. Stehlik J., Edwards L. B., Kucheryavaya A. Y., et al. International Society of Heart and Lung Transplantation The Registry of the International Society for Heart and Lung Transplantation: 29th official adult heart transplant report-2012. J Heart Lung Transplant: 2012; 31 10 1052 1064
4. Mason D. P., Brown C. R., Murthy S. C., et al. Growing single-center experience with lung transplantation using donation after cardiac death. Ann Thorac Surg: 2012; 94 2 406 411, discussion 411-412
5. Botha P., Trivedi D., Weir C. J., et al. Extended donor criteria in lung transplantation: impact on organ allocation. J Thorac Cardiovasc Surg: 2006; 131 5 1154 1160
6. Snell G. I., Griffiths A., Levvey B. J., Oto T. Availability of lungs for transplantation: exploring the real potential of the donor pool. J Heart Lung Transplant: 2008; 27 6 662 667
7. Snell G. I., Westall G. P. Selection and management of the lung donor. Clin Chest Med: 2011; 32 2 223 232
8. Cypel M., Yeung J. C., Liu M., et al. Normothermic ex vivo lung perfusion in clinical lung transplantation. N Engl J Med: 2011; 364 15 1431 1440
9. Ingemansson R., Eyjolfsson A., Mared L., et al. Clinical transplantation of initially rejected donor lungs after reconditioning ex vivo. Ann Thorac Surg: 2009; 87 1 255 260
10. Detry O., Le Dinh H., Noterdaeme T., et al. Categories of donation after cardiocirculatory death. Transplant Proc: 2012; 44 5 1189 1195
11. Kootstra G., Daemen J. H., Oomen A. P. Categories of non-heart-beating donors. Transplant Proc: 1995; 27 5 2893 2894
12. Egan T. M. Non-heart-beating donors in thoracic transplantation. J Heart Lung Transplant: 2004; 23 1 3 10
13. Steen S., Sjöberg T., Pierre L., Liao Q., Eriksson L., Algotsson L. Transplantation of lungs from a non-heart-beating donor. Lancet: 2001; 357 9259 825 829
14. Gomez-de-Antonio D., Campo-Cañaveral J. L., Crowley S., et al. Clinical lung transplantation from uncontrolled non-heart-beating donors revisited. J Heart Lung Transplant: 2012; 31 4 349 353
15. Mason D. P., Rajeswaran J., Li L., et al. Effect of changes in postoperative spirometry on survival after lung transplantation. J Thorac Cardiovasc Surg: 2012; 144 1 197 203
16. Van De Wauwer C., Verschuuren E. A., van der Bij W., Nossent G. D., Erasmus M. E. The use of non-heart-beating lung donors category III can increase the donor pool. Eur J Cardiothorac Surg: 2011; 39 6 e175 e180, discussion e180
17. Zych B., Popov A. F., Amrani M., et al. Lungs from donation after circulatory death donors: an alternative source to brain-dead donors? Midterm results at a single institution. Eur J Cardiothorac Surg: 2012; 42 3 542 549
18. Levvey B. Excellent early results of Australian DCD lung transplantation. J Heart Lung Transplant: 2010; 31 2 S63 S64
19. Kang C. H., Anraku M., Cypel M., et al. Transcriptional signatures in donor lungs from donation after cardiac death vs after brain death: a functional pathway analysis. J Heart Lung Transplant: 2011; 30 3 289 298
20. Stamenkovic S., Van Raemdonck D., Verleden G., et al. Bilateral lobar lung transplantation-the first two cases in Belgium. Acta Chir Belg: 2007; 107 2 201 204
21. Keating D. T., Westall G. P., Marasco S. F., et al. Paediatric lobar lung transplantation: addressing the paucity of donor organs. Med J Aust: 2008; 189 3 173 175
22. Sweet S. C., Wong H. H., Webber S. A., et al. Pediatric transplantation in the United States, 1995-2004. Am J Transplant: 2006; 6 5, Pt 2 1132 1152
23. Tydén G., Kumlien G., Genberg H., Sandberg J., Lundgren T., Fehrman I. ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab. Am J Transplant: 2005; 5 1 145 148
24. Nelson P. W., Bryan C. F. When will real benefits for minority patients be realized with A2-gt;B transplants? Transplantation: 2010; 89 11 1310 1311
25. Banner N. R., Rose M. L., Cummins D., et al. Management of an ABO-incompatible lung transplant. Am J Transplant: 2004; 4 7 1192 1196
26. Pierson R. N. III, Loyd J. E., Goodwin A., et al. Successful management of an ABO-mismatched lung allograft using antigen-specific immunoadsorption, complement inhibition, and immunomodulatory therapy. Transplantation: 2002; 74 1 79 84
27. Strüber M., Warnecke G., Hafer C., et al. Intentional ABO-incompatible lung transplantation. Am J Transplant: 2008; 8 11 2476 2478
28. Grasemann H., de Perrot M., Bendiak G. N., et al. ABO-incompatible lung transplantation in an infant. Am J Transplant: 2012; 12 3 779 781
29. Strüber M., Warnecke G., Hafer C., et al. Intentional ABO-incompatible lung transplantation. Am J Transplant: 2008; 8 11 2476 2478
30. Patel M., Carby M., Rice A., Cummins D., Banner N. R. Medium-term outcome of an ABO incompatible lung transplant. Am J Transplant: 2010; 10 3 702 703
31. Barnett A. N., Hudson A., Hadjianastassiou V. G., et al. Distribution of ABO blood group antibody titers in pediatric patients awaiting renal transplantation: implications for organ allocation policy. Transplantation: 2012; 94 4 362 368
32. Kobayashi T., Liu D., Ogawa H., et al. Removal of blood group A/B antigen in organs by ex vivo and in vivo administration of endo-beta-galactosidase (ABase) for ABO-incompatible transplantation. Transpl Immunol: 2009; 20 3 132 138
33. Yamane M., Sano Y., Toyooka S., Okazaki M., Date H., Oto T. Living-donor lobar lung transplantation for pulmonary complications after hematopoietic stem cell transplantation. Transplantation: 2008; 86 12 1767 1770
34. Bando T., Date H., Minami M., et al. First registry report: lung transplantation in Japan: The Japanese Society of Lung and Heart-Lung Transplantation. Gen Thorac Cardiovasc Surg: 2008; 56 1 17 21
35. Sundaresan S., Trachiotis G. D., Aoe M., Patterson G. A., Cooper J. D. Donor lung procurement: assessment and operative technique. Ann Thorac Surg: 1993; 56 6 1409 1413
36. Orens J. B., Boehler A., de Perrot M., et al. Pulmonary Council, International Society for Heart and Lung Transplantation A review of lung transplant donor acceptability criteria. J Heart Lung Transplant: 2003; 22 11 1183 1200
37. Botha P., Rostron A. J., Fisher A. J., Dark J. H. Current strategies in donor selection and management. Semin Thorac Cardiovasc Surg: 2008; 20 2 143 151
38. Van Raemdonck D., Neyrinck A., Verleden G. M., et al. Lung donor selection and management. Proc Am Thorac Soc: 2009; 6 1 28 38
39. Snell G. I., Westall G. P. Donor selection and management. Curr Opin Organ Transplant: 2009; 14 5 471 476
40. Pierre A. F., Sekine Y., Hutcheon M. A., Waddell T. K., Keshavjee S. H. Marginal donor lungs: a reassessment. J Thorac Cardiovasc Surg: 2002; 123 3 421 427, discussion, 427-428
41. Schiavon M., Falcoz P. E., Santelmo N., Massard G. Does the use of extended criteria donors influence early and long-term results of lung transplantation? Interact Cardiovasc Thorac Surg: 2012; 14 2 183 187
42. Meers C., Van Raemdonck D., Verleden G. M., et al. The number of lung transplants can be safely doubled using extended criteria donors; a single-center review. Transpl Int: 2010; 23 6 628 635
43. Levvey B. The Lung Allocation Score in a non-US lung transplant program. J Heart Lung Transplant: 2009; 29 2 S135
44. Gabbay E., Williams T. J., Griffiths A. P., et al. Maximizing the utilization of donor organs offered for lung transplantation. Am J Respir Crit Care Med: 1999; 160 1 265 271
45. Snell G. I., Griffiths A., Macfarlane L., et al. Maximizing thoracic organ transplant opportunities: the importance of efficient coordination. J Heart Lung Transplant: 2000; 19 4 401 407
46. Oto T., Levvey B. J., Whitford H., et al. Feasibility and utility of a lung donor score: correlation with early post-transplant outcomes. Ann Thorac Surg: 2007; 83 1 257 263
47. Iribarne A., Russo M. J., Davies R. R., et al. Despite decreased wait-list times for lung transplantation, lung allocation scores continue to increase. Chest: 2009; 135 4 923 928
48. Porro G. A., Valenza F., Coppola S., et al. Use of the Oto lung donor score to analyze the 2010 donor pool of the Nord Italia Transplant program. Transplant Proc: 2012; 44 7 1830 1834
49. Reyes K. G., Mason D. P., Thuita L., et al. Guidelines for donor lung selection: time for revision? Ann Thorac Surg: 2010; 89 6 1756 1764, discussion 1764-1765
50. Organ Procurement and Transplant Network: 2006; Annual Report. http://www.optn.org/AR2006
51. Zafar F., Khan M. S., Heinle J. S., et al. Does donor arterial partial pressure of oxygen affect outcomes after lung transplantation? A review of more than 12,000 lung transplants. J Thorac Cardiovasc Surg: 2012; 143 4 919 925
52. Government of Australia Deaths in Australia. Canberra, Australia Australian Bureau of Statistics: 2008; 73
53. Opdam H. I., Silvester W. Potential for organ donation in Victoria: an audit of hospital deaths. Med J Aust: 2006; 185 5 250 254
54. Ojo A. O., Wolfe R. A., Leichtman A. B., Dickinson D. M., Port F. K., Young E. W. A practical approach to evaluate the potential donor pool and trends in cadaveric kidney donation. Transplantation: 1999; 67 4 548 556
55. Meyers B. F., Patterson G. A. Current status of lung transplantation. Adv Surg: 2000; 34 301 318
56. De Perrot M., Waddell T. K., Shargall Y., et al. Impact of donors aged 60 years or more on outcome after lung transplantation: results of an 11-year single-center experience. J Thorac Cardiovasc Surg: 2007; 133 2 525 531
57. Penn I., Halgrimson C. G., Starzl T. E. De novo malignant tumors in organ transplant recipients. Transplant Proc: 1971; 3 1 773 778
58. Chen F., Karolak W., Cypel M., Keshavjee S., Pierre A. Intermediate-term outcome in lung transplantation from a donor with glioblastoma multiforme. J Heart Lung Transplant: 2009; 28 10 1116 1118
59. Armanios M. Y., Grossman S. A., Yang S. C., et al. Transmission of glioblastoma multiforme following bilateral lung transplantation from an affected donor: case study and review of the literature. Neuro-oncol: 2004; 6 3 259 263
60. Chen H., Shah A. S., Girgis R. E., Grossman S. A. Transmission of glioblastoma multiforme after bilateral lung transplantation. J Clin Oncol: 2008; 26 19 3284 3285
61. Penn I. Donor transmitted disease: cancer. Transplant Proc: 1991; 23 5 2629 2631
62. Bajaj N. S., Watt C., Hadjiliadis D., et al. Donor transmission of malignant melanoma in a lung transplant recipient 32 years after curative resection. Transpl Int: 2010; 23 7 e26 e31
63. Gandhi M. J., Strong D. M. Donor derived malignancy following transplantation: a review. Cell Tissue Bank: 2007; 8 4 267 286
64. Kauffman H. M., Cherikh W. S., McBride M. A., Cheng Y., Hanto D. W. Deceased donors with a past history of malignancy: an organ procurement and transplantation network/united network for organ sharing update. Transplantation: 2007; 84 2 272 274
65. Bonde P. N., Patel N. D., Borja M. C., et al. Impact of donor lung organisms on post-lung transplant pneumonia. J Heart Lung Transplant: 2006; 25 1 99 105
66. Avlonitis V. S., Krause A., Luzzi L., et al. Bacterial colonization of the donor lower airways is a predictor of poor outcome in lung transplantation. Eur J Cardiothorac Surg: 2003; 24 4 601 607
67. Mattner F., Kola A., Fischer S., et al. Impact of bacterial and fungal donor organ contamination in lung, heart-lung, heart and liver transplantation. Infection: 2008; 36 3 207 212
68. Len O., Gavaldà J., Blanes M., et al. Spanish Research Network for the Study of Infection in Transplantation Donor infection and transmission to the recipient of a solid allograft. Am J Transplant: 2008; 8 11 2420 2425
69. Palacios G., Druce J., Du L., et al. A new arenavirus in a cluster of fatal transplant-associated diseases. N Engl J Med: 2008; 358 10 991 998
70. Iwamoto M., Jernigan D. B., Guasch A., et al. West Nile Virus in Transplant Recipients Investigation Team Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med: 2003; 348 22 2196 2203
71. Srinivasan A., Burton E. C., Kuehnert M. J., et al. Rabies in Transplant Recipients Investigation Team Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med: 2005; 352 11 1103 1111
72. Halpern S. D., Shaked A., Hasz R. D., Caplan A. L. Informing candidates for solid-organ transplantation about donor risk factors. N Engl J Med: 2008; 358 26 2832 2837
73. Fong T. L., Cho Y. W., Hou L., Hutchinson I. V., Barbers R. G., Herrington C. S. Outcomes after lung transplantation and practices of lung transplant programs in the United States regarding hepatitis C seropositive recipients. Transplantation: 2011; 91 11 1293 1296
74. Davern T. J., Chalasani N., Fontana R. J., et al. Drug-Induced Liver Injury Network (DILIN) Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology: 2011; 141 5 1665 1672, e1-e9
75. Bonser R. S., Taylor R., Collett D., Thomas H. L., Dark J. H., Neuberger J. Cardiothoracic Advisory Group to NHS Blood and Transplant and the Association of Lung Transplant Physicians (UK) Effect of donor smoking on survival after lung transplantation: a cohort study of a prospective registry. Lancet: 2012; 380 9843 747 755
76. Macrae F. Cystic fibrosis sufferer given smoker's lungs in transplant dies of cancer. Available at: www.dailymail.co.uk/health/article-2249189
77. Oto T., Excell L., Griffiths A. P., Levvey B. J., Snell G. I. The implications of pulmonary embolism in a multiorgan donor for subsequent pulmonary, renal, and cardiac transplantation. J Heart Lung Transplant: 2008; 27 1 78 85
78. Ferraro P., Martin J., Dery J., et al. Late retrograde perfusion of donor lungs does not decrease the severity of primary graft dysfunction. Ann Thorac Surg: 2008; 86 4 1123 1129
79. Sapru A., Zaroff J. G., Pawlikowska L., et al. DOGMATIC Study Investigators The 4G/4G genotype of the PAI-1 (serpine-1) 4G/5G polymorphism is associated with decreased lung allograft utilization. Am J Transplant: 2012; 12 7 1848 1854
80. Kaneda H., Waddell T. K., de Perrot M., et al. Pre-implantation multiple cytokine mRNA expression analysis of donor lung grafts predicts survival after lung transplantation in humans. Am J Transplant: 2006; 6 3 544 551
81. Anraku M., Cameron M. J., Waddell T. K., et al. Impact of human donor lung gene expression profiles on survival after lung transplantation: a case-control study. Am J Transplant: 2008; 8 10 2140 2148
82. Ray M., Dharmarajan S., Freudenberg J., Zhang W., Patterson G. A. Expression profiling of human donor lungs to understand primary graft dysfunction after lung transplantation. Am J Transplant: 2007; 7 10 2396 2405
83. Oto T., Excell L., Griffiths A. P., et al. Association between primary graft dysfunction among lung, kidney and heart recipients from the same multiorgan donor. Am J Transplant: 2008; 8 10 2132 2139
84. Cooper D. K. Hormonal resuscitation therapy in the management of the brain-dead potential organ donor. Int J Surg: 2008; 6 1 3 4
85. Shah V. R. Aggressive management of multiorgan donor. Transplant Proc: 2008; 40 4 1087 1090
86. Venkateswaran R. V., Patchell V. B., Wilson I. C., et al. Early donor management increases the retrieval rate of lungs for transplantation. Ann Thorac Surg: 2008; 85 1 278 286, discussion 286
87. Rosendale J. D., Kauffman H. M., McBride M. A., et al. Aggressive pharmacologic donor management results in more transplanted organs. Transplantation: 2003; 75 4 482 487
88. Steen S., Sjöberg T., Liao Q., Bozovic G., Wohlfart B. Pharmacological normalization of circulation after acute brain death. Acta Anaesthesiol Scand: 2012; 56 8 1006 1012
89. Rostron A. J., Avlonitis V. S., Cork D. M., Grenade D. S., Kirby J. A., Dark J. H. Hemodynamic resuscitation with arginine vasopressin reduces lung injury after brain death in the transplant donor. Transplantation: 2008; 85 4 597 606
90. Minambres E., Ballesteros M. A., Rodrigo E., et al. Aggressive lung donor management increases graft procurement without increasing renal graft loss after transplantation. Clin Transplant: 2013; 27 1 52 59
91. Christmas A. B., Bogart T. A., Etson K. E., et al. The reward is worth the wait: a prospective analysis of 100 consecutive organ donors. Am Surg: 2012; 78 3 296 299
92. Mascia L., Pasero D., Slutsky A. S., et al. Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: a randomized controlled trial. JAMA: 2010; 304 23 2620 2627
93. Marasco S. F., Bailey M., McGlade D., et al. Effect of donor preservation solution and survival in lung transplantation. J Heart Lung Transplant: 2011; 30 4 414 419
94. Cypel M., Yeung J. C., Hirayama S., et al. Technique for prolonged normothermic ex vivo lung perfusion. J Heart Lung Transplant: 2008; 27 12 1319 1325
95. Aigner C., Slama A., Hötzenecker K., et al. Clinical ex vivo lung perfusion-pushing the limits. Am J Transplant: 2012; 12 7 1839 1847
96. Zych B., Popov A. F., Stavri G., et al. Early outcomes of bilateral sequential single lung transplantation after ex-vivo lung evaluation and reconditioning. J Heart Lung Transplant: 2012; 31 3 274 281
97. Cypel M., Yeung J. C., Machuca T., et al. Experience with the first 50 ex vivo lung perfusions in clinical transplantation. J Thorac Cardiovasc Surg: 2012; 144 5 1200 1206
98. Dong B. M., Abano J. B., Egan T. M. Nitric oxide ventilation of rat lungs from non-heart-beating donors improves posttransplant function. Am J Transplant: 2009; 9 12 2707 2715
99. Inci I., Ampollini L., Arni S., et al. Ex vivo reconditioning of marginal donor lungs injured by acid aspiration. J Heart Lung Transplant: 2008; 27 11 1229 1236
100. Inci I., Zhai W., Arni S., et al. Fibrinolytic treatment improves the quality of lungs retrieved from non-heart-beating donors. J Heart Lung Transplant: 2007; 26 10 1054 1060
101. Hirayama S., Cypel M., Sato M., et al. Activated protein C in ischemia-reperfusion injury after experimental lung transplantation. J Heart Lung Transplant: 2009; 28 11 1180 1184
102. Ishiyama T., Dharmarajan S., Hayama M., Moriya H., Grapperhaus K., Patterson G. A. Inhibition of nuclear factor kappaB by IkappaB superrepressor gene transfer ameliorates ischemia-reperfusion injury after experimental lung transplantation. J Thorac Cardiovasc Surg: 2005; 130 1 194 201
103. Yeung J. C., Wagnetz D., Cypel M., et al. Ex vivo adenoviral vector gene delivery results in decreased vector-associated inflammation pre- and post-lung transplantation in the pig. Mol Ther: 2012; 20 6 1204 1211
104. Cypel M., Rubacha M., Yeung J., et al. Normothermic ex vivo perfusion prevents lung injury compared to extended cold preservation for transplantation. Am J Transplant: 2009; 9 10 2262 2269